Interleukin-2 Receptor and Angiotensin-Converting Enzyme as Markers for Ocular Sarcoidosis.

Interleukin-2 Receptor and Angiotensin-Converting Enzyme as Markers for Ocular Sarcoidosis.

PURPOSE:To study the impact of soluble IL2 receptor (sIL2R), chest x-ray (CxR), and angiotensin-converting enzyme (ACE) as markers for sarcoidosis in uveitis patients. DESIGN:Retrospective study. METHODS:Serum concentrations of sIL2R and ACE were measured in patients with active uveitis. Those with...

Full description

Bibliographic Details
Main Authors:	Enken Gundlach, Michael Marcus Hoffmann, Antje Prasse, Sonja Heinzelmann, Thomas Ness
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2016-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4723126?pdf=render

Similar Items

Utility of angiotensin-converting enzyme activity in aqueous humor in the diagnosis of ocular sarcoidosis
by: Violeta Mihailovic-Vucinic, et al.
Published: (2017-01-01)

YKL-40, Soluble IL-2 Receptor, Angiotensin Converting Enzyme and C-Reactive Protein: Comparison of Markers of Sarcoidosis Activity
by: Pelin Uysal, et al.
Published: (2018-08-01)

Optic nerve head granuloma, retinal vasculitis and elevated levels of angiotensin-converting enzyme: Dilemma of forme fruste ocular sarcoidosis
by: Ravi Bypareddy, et al.
Published: (2019-01-01)

The Comparative Value of Serum Angiotensin Converting Enzyme (ACE) and Lysozyme and the use of Polyclonal Antibody Activation in the Work-up of Ocular Sarcoidosis
by: Ioannis Papasavvas, et al.
Published: (2021-03-01)

Raman spectroscopic detection of interleukin-10 and angiotensin converting enzyme
by: Shuo Zhang, et al.
Published: (2021-04-01)

Insertion/Deletion Polymorphisms and Serum Angiotensin-converting Enzyme Levels in Iranian Patients with Sarcoidosis
by: Alireza JAVADI, et al.
Published: (2016-11-01)

Angiotensin-Converting Enzyme Inhibitors Versus Angiotensin Receptor Blockers
by: Neil Poulter, et al.
Published: (2006-06-01)

Serum angiotensin converting enzyme (SACE) in sarcoidosis : Studies to assess the usefulness of SACE as a diagnostic test and as a monitor of progress in sarcoidosis
by: Studdy, P. R.
Published: (1983)

Associations between the angiotensin-converting enzyme insertion/deletion polymorphism and susceptibility to sarcoidosis: A meta-analysis
by: Gwan Gyu Song, et al.
Published: (2015-03-01)

Ocular kinetics and safety of intravitreally injected angiotensin converting enzyme inhibitor lisinopril
by: Madhu Nath, et al.
Published: (2018-11-01)

The Fetal Safety of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers
by: Myla E. Moretti, et al.
Published: (2012-01-01)

Angiotensin Converting Enzyme Inhibitor/Angiotensin II Receptor Blockers and Pneumonia risk
by: Chia-Lin Liu, et al.
Published: (2010)

Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Angiotensin-Converting Enzyme 2 Levels: A Comprehensive Analysis Based on Animal Studies
by: Gábor Kriszta, et al.
Published: (2021-03-01)

Association of Interleukin 23 Receptor Gene with Sarcoidosis
by: Hyun Soo Kim, et al.
Published: (2011-01-01)

Angiotensin Converting Enzyme (ACE): A Marker for Personalized Feedback on Dieting
by: Shilpa Tejpal, et al.
Published: (2020-02-01)

Effect of angiotensin converting enzyme inhibitor and angiotensin II receptor blocker on the patients with sepsis
by: Hyun Woo Lee, et al.
Published: (2021-03-01)

Effects of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Contrast-Induced Nephropathy
by: Letian Zhou, et al.
Published: (2014-03-01)

Angiotensin Converting Enzyme 2, Angiotensin-(1-7), and Receptor Mas Axis in the Kidney
by: Sergio Veloso Brant Pinheiro, et al.
Published: (2012-01-01)

Structural determinants for binding to angiotensin converting enzyme 2 (ACE2) and angiotensin receptors
by: Daniel eClayton, et al.
Published: (2015-01-01)

Combination of aliskiren with angiotensin-converting enzyme-inhibitor and angiotensin receptor blocker — mechanism of action
by: Luis M Ruilope
Published: (2008-03-01)

Angiotensin-converting enzyme inhibitors
by: David García Barreto, et al.
Published: (2014-03-01)

Homologues of the angiotensin converting enzyme
by: Elliott, Joann Louise
Published: (2005)

Dietary Potassium Downregulates Angiotensin-I Converting Enzyme, Renin, and Angiotensin Converting Enzyme 2
by: Carlos P. Vio, et al.
Published: (2020-06-01)

Angiotensin-converting enzyme activity and inhibition in dogs with cardiac disease and an angiotensin-converting enzyme polymorphism
by: Kathryn M Meurs, et al.
Published: (2017-10-01)

Onset of Hyperkalemia following the Administration of Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker
by: Hye-Ran Jun, et al.
Published: (2021-01-01)

Usage of Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker in Hypertension Intracerebral Hemorrhage
by: Zhang C, et al.
Published: (2021-02-01)

Effects of Spironolactone in Combination with Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers in Patients with Proteinuria
by: Ha Yeon Kim, et al.
Published: (2014-12-01)

Hyponatremia Induced by Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers-A Pilot Study
by: S Bhuvaneshwari, et al.
Published: (2018-07-01)

Hyperkalemia Associated with Angiotensin Converting Enzyme Inhibitor or Angiotensin Receptor Blockers in Chronic Kidney Disease
by: Yudi Her Oktaviono, et al.
Published: (2020-04-01)

Safety and efficacy of angiotensin converting enzyme inhibitors and angiotensin receptor blockers in chronic allograft injury
by: P R Shah, et al.
Published: (2011-01-01)

Angiotensin-(1-7)/Angiotensin-Converting Enzyme 2/Mas Receptor Axis and Related Mechanisms
by: Anderson J. Ferreira, et al.
Published: (2012-01-01)

Is there any difference between angiotensin converting enzyme inhibitors and angiotensin receptor blockers for heart failure?
by: Carmen Rain, et al.
Published: (2015-07-01)

Angiotensin Converting Enzyme and Angiotensin II Type 1 Receptor Polymorphisms in Patients with Coronary Aneurysms
by: Helbecque Nicole, et al.
Published: (2003-08-01)

Angiotensin-converting enzyme inhibitor or Angiotensin receptor blocker in preventing stroke among hypertension patients
by: Pi-huei Chao, et al.
Published: (2009)

The controversy of using angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in COVID-19 patients
by: Amer Harky, et al.
Published: (2021-01-01)

Review: The practical aspects of combination therapy with angiotensin receptor blockers and angiotensin-converting enzyme inhibitors
by: Domenic A Sica
Published: (2002-06-01)

Relating angiotensin‐converting enzyme inhibitors or angiotensin receptor blockers with incidence or mortality of COVID‐19
by: Martin C.S. Wong, et al.
Published: (2020-10-01)

Usefulness of Combined Measurement of Serum Soluble IL-2R and Angiotensin-Converting Enzyme in the Detection of Uveitis Associated with Japanese Sarcoidosis
by: Ishihara M, et al.
Published: (2020-08-01)

POLYMORPHISM OF THE INTERLEUKIN-6, INTERLEUKIN-10, SUPEROXIDE DISMUTASE AND ANGIOTENSIN CONVERTING ENZYME GENES, AND THE RISK OF ATRIAL FIBRILLATION AFTER CARDIOSURGERY
by: O. A. Rubanenko, et al.
Published: (2016-10-01)

Balance between angiotensin converting enzyme and angiotensin converting enzyme 2 in patients with chronic heart failure
by: Jiang Wang, et al.
Published: (2015-09-01)

Cannot write session to /tmp/vufind_sessions/sess_7bvlvqmhagbv65j312t0f4p2ii